US2023233626A1PendingUtilityA1

Method and composition for production of a phytonutrient in a microbiome

Assignee: ACCESS BUSINESS GROUP INT LLCPriority: Sep 24, 2019Filed: Mar 31, 2023Published: Jul 27, 2023
Est. expirySep 24, 2039(~13.2 yrs left)· nominal 20-yr term from priority
A23V 2002/00A23V 2400/249A23V 2400/533A23V 2400/51A23V 2400/113A23V 2400/529A23V 2400/519A23V 2400/517A23V 2400/515A23V 2400/123A23V 2400/125A23V 2400/231A23V 2400/169A23V 2400/173A23V 2400/165A23V 2400/181A23V 2400/177A23V 2400/143A23V 2400/121A23K 50/00A23K 50/50A23K 50/40A23K 50/80A23K 50/75A23K 50/30A23K 50/10A23K 20/163A23K 20/111A23K 20/121A23K 10/18A23L 33/105A61K 31/352A61K 35/747A61K 31/353A61K 31/7032A61K 31/7048A61K 35/745A61P 3/02A23L 33/135C12N 1/20A23V 2200/3202A23V 2200/3204A23V 2250/21164A61K 2300/00
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method useful for providing a phytonutrient to a subject via mediation of the subject’s microbiome is disclosed. The method includes administering a phytofunctional composition to a subject change the phytonutrient producer status of the subject. The method may also include identifying a phytonutrient producer status of the subject by assessing a level of at least one of a preselected phytonutrient and a preselected phytonutrient precursor compound within the subject. A phytofunctional composition useful in the method is also disclosed, and comprises a phytonutrient precursor compound and an active agent. The active agent comprises a probiotic and/or a prebiotic, and is adapted to mediate production of the preselected phytonutrient in the gastrointestinal tract of the subject, thereby changing the phytonutrient producer status of the subject.

Claims

exact text as granted — not AI-modified
1 - 14 . (canceled) 
     
     
         15 . A phytofunctional composition for mediating a subject’s microbial metabolism, the phytofunctional composition comprising:
 a phytonutrient precursor compound, and 
 an active agent comprising a probiotic or a prebiotic, the active agent being adapted to mediate production of a preselected phytonutrient from the phytonutrient precursor compound in the gastrointestinal tract of the subject. 
 
     
     
         16 . The phytofunctional composition of  claim 15 , wherein the phytonutrient precursor compound comprises: (i) quercetin; (ii) cyanidin-3-glucoside; (iii) epigallocatechin; (iv) hesperidin; (v) ellagic acid; (vi) secoisolariciresinol diglucoside; (vii) a metabolite of any of (i)-(vi); or (viii) any combination of (i)-(vii). 
     
     
         17 . The phytofunctional composition of  claim 15 , wherein the active agent of the phytofunctional composition comprises the probiotic, and wherein the probiotic comprises a bacterial strain capable of metabolizing the phytonutrient precursor compound to increase the level of the preselected phytonutrient in the gastrointestinal tract of the subject. 
     
     
         18 . The phytofunctional composition of  claim 17 , wherein the probiotic comprises: (i) a Bifidobacterium spp.; (ii) a Lactobacillus spp.; or (iii) both (i) and (ii). 
     
     
         19 . The phytofunctional composition of  claim 15 , wherein the phytonutrient is preselected from 2,4,6-trihydroxybenzoic acid, parargonidin-3-O-glucoside, hesperitin, urolithin A, hydroferulic acid, hydrocaffeic acid, and dihydroxyphenylacetic acid. 
     
     
         20 . The phytofunctional composition of  claim 15 , wherein the phytonutrient precursor compound is further defined as a first phytonutrient precursor compound and the preselected phytonutrient is further defined as a first preselected phytonutrient; wherein the phytofunctional composition further comprises a second phytonutrient precursor compound; and wherein the active agent is adapted to mediate production of the first preselected phytonutrient from the first phytonutrient precursor compound and a second preselected phytonutrient from the second phytonutrient precursor compound in the gastrointestinal tract of the subject. 
     
     
         21 . A multi-dose treatment regimen comprising the phytofunctional composition of  claim 15 , where the amount of the phytofunctional composition in each dose and timing of each dose is selected to maintain the changed phytonutrient-producer status of the subject for a majority of a treatment period. 
     
     
         22 . A subject-specific phytofunctional composition for mediating a subject’s microbial metabolism based on the subject’s particular phytonutrient-producer status, the subject-specific phytofunctional composition comprising:
 a phytonutrient precursor compound identified by a phytonutrient-producer status of the subject; and 
 an active agent comprising a probiotic, the active agent being adapted to mediate production of a preselected phytonutrient from the phytonutrient precursor compound in the gastrointestinal tract of the subject, thereby changing the phytonutrient-producer status of the subject; 
 wherein the probiotic comprises a bacterial strain capable of metabolizing the phytonutrient precursor compound to increase the level of the preselected phytonutrient in the gastrointestinal tract of the subject. 
 
     
     
         23 . The subject-specific phytofunctional composition of  claim 22 , wherein the active agent is also identified based on the phytonutrient-producer status of the subject. 
     
     
         24 . The subject-specific phytofunctional composition of  claim 22 , wherein the phytonutrient precursor compound comprises a processed plant material, optionally wherein the processed plant material is extracted, distilled, hydrolyzed, or otherwise derived from plant material, via natural and/or synthetic methods. 
     
     
         25 . The subject-specific phytofunctional composition of  claim 22 , wherein the phytonutrient precursor compound comprises metabolized plant material produced from microbial metabolism and/or digestion. 
     
     
         26 . A multi-dose treatment regimen comprising the subject-specific phytofunctional composition of  claim 22 , where the amount of the phytofunctional composition in each dose and timing of each dose is selected to maintain the changed phytonutrient-producer status of the subject for a majority of a treatment period. 
     
     
         27 . A kit for making and administering the subject-specific phytofunctional composition of  claim 22 , the kit including the probiotic component and the phytonutrient precursor component, wherein the components are provided for compounding and administration of the subject-specific phytofunctional composition. 
     
     
         28 . A phytofunctional composition for increasing phytonutrient production of a subject, the phytofunctional composition comprising:
 a phytonutrient that is not metabolized by the subject; and   an active agent comprising a probiotic or a prebiotic, the active agent for metabolizing the phytonutrient to increase the level and production of the metabolized phytonutrients in the subject.   
     
     
         29 . The phytofunctional composition of  claim 28 , wherein the phytonutrient precursor compound comprises a processed plant material, optionally wherein the processed plant material is extracted, distilled, hydrolyzed, or otherwise derived from plant material, via natural and/or synthetic methods. 
     
     
         30 . The phytofunctional composition of  claim 28 , wherein the active agent is identified based on the phytonutrient-producer status of the subject and determining the phytonutrient-producer status of the subject is further defined as comparing a biological concentration and/or excretion amount of a phytonutrient of the subject against commensurate measurements obtained from other subjects. 
     
     
         31 . The phytofunctional composition of  claim 28 , wherein the active agent is identified based on a population study to determine the phytonutrient-producer status of various individuals among the population. 
     
     
         32 . The phytofunctional composition of  claim 28 , wherein the active agent of the phytofunctional composition comprises the prebiotic, and wherein the prebiotic comprises at least one fiber. 
     
     
         33 . The phytofunctional composition of  claim 28 , wherein the active agent of the phytofunctional composition comprises the prebiotic, and wherein the prebiotic comprises at least one starch. 
     
     
         34 . A multi-dose treatment regimen comprising the phytofunctional composition of  claim 28 , where the amount of the phytofunctional composition in each dose and timing of each dose is selected to maintain the changed phytonutrient-producer status for a majority of a treatment period.

Join the waitlist — get patent alerts

Track US2023233626A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.